Chikashi Nakanishi

Summary

Country: Japan

Publications

  1. ncbi Post-transplantation lymphoproliferative disorder in living-donor liver transplantation: a single-center experience
    Chikashi Nakanishi
    Division of Advanced Surgical Science and Technology, Graduate School of Medicine, Tohoku University, 1 1 Seiryou Machi, Aobaku, Sendai, 980 8574, Japan
    Surg Today 42:741-51. 2012
  2. ncbi Nuclear factor-kappaB inhibitors as sensitizers to anticancer drugs
    Chikashi Nakanishi
    Tokyo Metropolitan Cancer and Infectious Disease Center, Komagome Hospital, 3 18 22, Honkomagome, Bunkyoku, Tokyo 113 8677, Japan
    Nat Rev Cancer 5:297-309. 2005
  3. ncbi Steroid-resistant late acute rejection after a living donor liver transplantation: case report and review of the literature
    Chikashi Nakanishi
    Division of Advanced Surgical Science and Technology, Tohoku University Graduate School of Medicine, Sendai, Japan
    Tohoku J Exp Med 211:195-200. 2007
  4. ncbi Treatment with L-valine ameliorates liver fibrosis and restores thrombopoiesis in rats exposed to carbon tetrachloride
    Chikashi Nakanishi
    Division of Advanced Surgical Science and Technology, Graduate School of Medicine, Tohoku University, Sendai, Japan
    Tohoku J Exp Med 221:151-9. 2010

Collaborators

Detail Information

Publications4

  1. ncbi Post-transplantation lymphoproliferative disorder in living-donor liver transplantation: a single-center experience
    Chikashi Nakanishi
    Division of Advanced Surgical Science and Technology, Graduate School of Medicine, Tohoku University, 1 1 Seiryou Machi, Aobaku, Sendai, 980 8574, Japan
    Surg Today 42:741-51. 2012
    ..This retrospective study evaluates a single-institution experience of five cases of PTLD after living-donor liver transplantation (LDLT)...
  2. ncbi Nuclear factor-kappaB inhibitors as sensitizers to anticancer drugs
    Chikashi Nakanishi
    Tokyo Metropolitan Cancer and Infectious Disease Center, Komagome Hospital, 3 18 22, Honkomagome, Bunkyoku, Tokyo 113 8677, Japan
    Nat Rev Cancer 5:297-309. 2005
    ..What evidence is there that inhibitors of NF-kappaB might promote apoptosis in cancer cells and can NF-kappaB inhibitors be used to overcome resistance to chemotherapeutic agents?..
  3. ncbi Steroid-resistant late acute rejection after a living donor liver transplantation: case report and review of the literature
    Chikashi Nakanishi
    Division of Advanced Surgical Science and Technology, Tohoku University Graduate School of Medicine, Sendai, Japan
    Tohoku J Exp Med 211:195-200. 2007
    ..In this report, we have shown that deoxyspergualin is safe and effective for treatment of steroid-resistant late acute rejection, preventing from graft loss of chronic rejection...
  4. ncbi Treatment with L-valine ameliorates liver fibrosis and restores thrombopoiesis in rats exposed to carbon tetrachloride
    Chikashi Nakanishi
    Division of Advanced Surgical Science and Technology, Graduate School of Medicine, Tohoku University, Sendai, Japan
    Tohoku J Exp Med 221:151-9. 2010
    ..These results indicate that L-valine treatment ameliorates liver fibrosis and restores thrombopoiesis in rats exposed to CCl(4). Therefore, L-valine supplementation may be helpful for patients with liver cirrhosis...